Importance of Interdisciplinary Collaboration regarding Updated Activated Partial Thromboplastin Time Reporting for Heparin

Abstract

Get full access to this article

View all access options for this article.

References

Hirsh

Anand

S.S.

Halperin

J.L.

Guide to anticoagulant therapy: Heparin: A statement for healthcare professionals from the American Heart Association. Circulation. 2001; 103: 2994–3018.

Garcia

D.A.

Baglin

T.P.

Weitz

J.I.

Parenteral anticoagulants: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141(2 Suppl): e24S–e43S.

Volles

D.F.

Ancell

C.J.

Michael

K.A.

Establishing an institution-specific therapeutic range for heparin. Am J Health Syst Pharm. 1998; 55: 2002–2006.

Handbook for Laboratory Quality Management System: The Importance of Laboratory Quality. Lyon, France: World Health Organization International Health Regulations Coordination; 2011.

American Association of Critical-Care Nurses. AACN Standards for establishing and sustaining healthy work environments: A journey to excellence. Am J Crit Care. 2005; 14(3): 187–197.